Prolactinoma natural history, complications, and prognosis: Difference between revisions
YazanDaaboul (talk | contribs) No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Prolactinoma}} | {{Prolactinoma}} | ||
{{CMG}} {{AE}}{{Faizan}} | {{CMG}} {{AE}}, {{Anmol}}{{Faizan}} | ||
==Overview== | ==Overview== | ||
If left untreated, 95% of cases of [[prolactinoma]] will not show any signs of growth during the first 4 | If left untreated, 95% of cases of [[prolactinoma]] will not show any signs of growth during the first 4 to 6 year period. Complications of prolactinoma include [[pituitary apoplexy]], [[vision loss]]. Prognosis is generally excellent for cases of microprolactinoma. | ||
==Natural History== | ==Natural History== | ||
If left untreated, 95% of cases of [[prolactinoma]] will not show any signs of growth during the first 4 | If left untreated, 95% of cases of [[prolactinoma]] will not show any signs of growth during the first 4 to 6 year period. | ||
==Complications== | ==Complications== | ||
Complications of [[prolactinoma]] include: | Complications of [[prolactinoma]] include: | ||
*[[ | *Pituiary apoplexy<ref name="pmid15191331">{{cite journal| author=Liu JK, Couldwell WT| title=Contemporary management of prolactinomas. | journal=Neurosurg Focus | year= 2004 | volume= 16 | issue= 4 | pages= E2 | pmid=15191331 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15191331 }} </ref> | ||
** [[Pituitary apoplexy]] usually presents with sudden onset of excruciating [[headache]], [[diplopia]], and visual impairment. | |||
** [[Headache]] is most common symptom and is associated with [[nausea]] and [[vomiting]] majority of time. | |||
{{Family tree/start}} | |||
{{Family tree | | | | A01 | | | |A01= Infarction in Prolactinoma}} | |||
{{Family tree | | | | |!| | | | | }} | |||
{{Family tree | | | | B01 | | | |B01= Rapid enlargement of tumor}} | |||
{{Family tree | | | | |!| | | | | }} | |||
{{Family tree | | | | C01 | | | |C01= Compression of sella and para sellar structures}} | |||
{{Family tree/end}} | |||
*Tumor regrowth (after resection) | *Tumor regrowth (after resection) | ||
*[[Blindness]] | *[[Blindness]] | ||
*In pregnancy excessive [[estrogen]] may cause increased tumor growth | *In [[pregnancy]] excessive [[estrogen]] may cause increased tumor growth. | ||
==Prognosis== | ==Prognosis== |
Revision as of 15:57, 21 July 2017
Prolactinoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Prolactinoma natural history, complications, and prognosis On the Web |
American Roentgen Ray Society Images of Prolactinoma natural history, complications, and prognosis |
FDA on Prolactinoma natural history, complications, and prognosis |
CDC on Prolactinoma natural history, complications, and prognosis |
Prolactinoma natural history, complications, and prognosis in the news |
Blogs on Prolactinoma natural history, complications, and prognosis |
Risk calculators and risk factors for Prolactinoma natural history, complications, and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: , Anmol Pitliya, M.B.B.S. M.D.[2]Faizan Sheraz, M.D. [3]
Overview
If left untreated, 95% of cases of prolactinoma will not show any signs of growth during the first 4 to 6 year period. Complications of prolactinoma include pituitary apoplexy, vision loss. Prognosis is generally excellent for cases of microprolactinoma.
Natural History
If left untreated, 95% of cases of prolactinoma will not show any signs of growth during the first 4 to 6 year period.
Complications
Complications of prolactinoma include:
- Pituiary apoplexy[1]
Infarction in Prolactinoma | |||||||||||||||||||
Rapid enlargement of tumor | |||||||||||||||||||
Compression of sella and para sellar structures | |||||||||||||||||||
- Tumor regrowth (after resection)
- Blindness
- In pregnancy excessive estrogen may cause increased tumor growth.
Prognosis
- Prognosis is excellent for cases of microprolactinoma.
- Depending on the size of the tumor and the extent of tumor resection, the rate of recurrence may range from 20% to 50%.
- The majority of recurrent prolactinomas develop within the first 5 years.[2]
References
- ↑ Liu JK, Couldwell WT (2004). "Contemporary management of prolactinomas". Neurosurg Focus. 16 (4): E2. PMID 15191331.
- ↑ http://www.niddk.nih.gov/health-information/health-topics/endocrine/prolactinoma/Pages/fact-sheet.aspx